Brad Weisgerber

Brad Weisgerber is the Head Trader at Casdin Capital, LLC, based in Hoboken, NJ, where he has served since 2015. In this role, he manages trading operations and execution across the firm’s portfolio, applying his extensive experience in equity and options markets to the firm's investment strategies. Casdin Capital specializes in long-term investments in the life sciences sector, with a particular focus on biotechnology, genomics, and healthcare innovation. Weisgerber’s trading responsibilities center on these sectors, where he plays a key part in executing trades and managing risk within healthcare and life science equities and derivatives.

Prior to joining Casdin Capital, Weisgerber held trading roles at Pura Vida Investments and Weiss Multi-Strategy Advisers, accumulating over a decade of experience in equity and options trading. His tenure at Weiss Multi-Strategy Advisers, spanning ten years, provided him with a strong foundation in multi-asset strategies and risk management, which he leverages in his current role at Casdin.

Weisgerber holds a finance degree from Villanova University, cementing his expertise in financial markets and investment analysis. His contributions to Casdin Capital, particularly in optimizing trade execution and portfolio risk for life sciences assets, underscore his status as a seasoned professional in healthcare and biotech investment trading.